Kidney effects.
Three kidney issues come up with sulfa drugs. Crystalluria โ drug crystals in the urine โ was historically a problem with high-dose sulfa antibiotics and remains a concern with modern sulfadiazine. An elevated serum creatinine on TMP-SMX often reflects competitive inhibition of tubular secretion, not a true fall in glomerular filtration rate. Interstitial nephritis is a rare allergic kidney reaction that can occur with sulfa antibiotics.
- Crystalluria
- Drug crystals form in acidic urine; mainly a concern with high-dose sulfadiazine.
- Creatinine rise on TMP-SMX
- Trimethoprim blocks creatinine secretion; the rise is usually benign and reverses on stopping.
- Interstitial nephritis
- Rare immune-mediated kidney injury; sometimes with fever, rash, eosinophilia.
- Other
- Hyperkalemia and hyponatremia on TMP-SMX (separate, but often grouped).
Crystalluria
Some sulfa antibiotics โ and their metabolites, especially the acetylated ones โ are poorly soluble at acidic urinary pH and can precipitate as crystals in the renal tubules. Crystals can cause direct tubular irritation, hematuria, occasional obstructive renal injury, and in extreme cases acute kidney injury.
The risk is highest with sulfadiazine at the high doses used for toxoplasmosis treatment, particularly in immunocompromised patients. Older sulfa drugs (sulfanilamide, sulfathiazole) had higher rates of crystalluria; that history is part of the reason their place in therapy is mostly historical. With routine doses of sulfamethoxazole/trimethoprim at usual indications, crystalluria is uncommon, though microscopic crystals are sometimes seen.
Adequate hydration is the standard preventive measure. For patients on high-dose sulfadiazine for toxoplasmosis, this is part of routine prescribing. Urinary alkalinisation (sodium bicarbonate) is sometimes added in selected cases. The clinical decision belongs to the prescribing physician.
The "elevated creatinine" on TMP-SMX
One of the most-discussed kidney effects is also one of the most often misunderstood. On TMP-SMX, serum creatinine often rises modestly within days of starting the drug. The rise is not, in most cases, a true fall in glomerular filtration rate.
Trimethoprim competitively inhibits the secretion of creatinine in the proximal renal tubule. Normally, a small fraction of urinary creatinine is added by tubular secretion on top of the bulk filtered by the glomerulus. When secretion is blocked, less creatinine appears in urine, and serum creatinine rises. The kidney's underlying filtration is unchanged โ measurements that bypass tubular secretion (cystatin C, inulin clearance) confirm this.
The clinical implication is that a 20% rise in serum creatinine on TMP-SMX is usually expected pharmacology, not nephrotoxicity. The level returns to baseline after the drug is stopped. Larger rises, or rises with other features (hyperkalemia, eosinophilia, sediment changes), warrant a closer look.
Interstitial nephritis
Acute interstitial nephritis (AIN) is an immune-mediated injury to the kidney's tubules and surrounding interstitium, recognised with many drug classes including sulfa antibiotics, NSAIDs, proton pump inhibitors, ฮฒ-lactams, and others. The classic triad of fever, rash, and eosinophilia is present in only a minority of cases. Many present simply as an unexplained rise in creatinine days to weeks into a drug course, sometimes with eosinophils in urine.
Diagnosis often requires kidney biopsy. Management is to stop the offending drug; corticosteroids are sometimes used in severe or non-resolving cases, though the evidence base is mixed. Most cases recover renal function partly or fully on drug withdrawal.
Hyperkalemia on TMP-SMX
Trimethoprim is structurally similar to amiloride and blocks the epithelial sodium channel in the distal nephron. The effect on potassium handling is the same as for amiloride: potassium is retained, serum potassium can rise. Effects are dose-related and more pronounced in patients with reduced kidney function, on other potassium-raising drugs (ACE inhibitors, ARBs, spironolactone, NSAIDs), or in older patients. Severe hyperkalemia on TMP-SMX has been reported, particularly in older patients on multiple potassium-sparing drugs. Routine prescribing in such patients sometimes includes a check of potassium and creatinine after a few days.
Hyponatremia
Hyponatremia on thiazides is well recognised. On TMP-SMX hyponatremia is also reported, particularly in older patients and at higher doses. Mild and clinically silent in many cases; occasionally severe enough to require attention.
Other patterns
Sulfa antibiotics have rarely been linked to other kidney patterns: glomerular disease in unusual cases, chronic interstitial damage with prolonged exposure, drug-induced lupus with kidney involvement. None of these is common, and most patients on a course of sulfa antibiotic have no clinically meaningful kidney effect at all.
The non-antibiotic sulfonamides
For the diuretics, the kidney effects are part of their pharmacology, not allergic phenomena. Loop diuretics can cause volume depletion and pre-renal azotemia, electrolyte loss, and rare interstitial nephritis. Thiazides can cause hyponatremia, hypokalemia, hyperuricemia. Acetazolamide alters urine pH and can promote calcium phosphate kidney stones. None of these is an allergic kidney reaction in the same sense as interstitial nephritis from antibiotics.